PROVIDUS Trademark

Trademark Overview


On Wednesday, July 30, 2025, a trademark application was filed for PROVIDUS with the United States Patent and Trademark Office. The USPTO has given the PROVIDUS trademark a serial number of 99310861. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, March 3, 2026. This trademark is owned by ITALFARMACO S.P.A.. The PROVIDUS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific and technological services, namely, scientific research, pharmaceutical drug development, and biochemical analysis in the field of drug discovery; medical research and conducting clinical trials for pharmaceutical products; data computer modeling services in the field of pharmaceutical development and medical technology; Scientific services and research namely conducting scientific pharmaceutical product feasibility studies and product designing medical devices and instruments for clinical trials; Scientific services and product design, namely conducting scientific pharmaceutical product feasibility studies and designing medical devices and instruments for clinical trials; Platform as a service (PAAS) comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; product research services, design and development of instruments for control and diagnostics; Scientific research; Electronic...

Healthcare services, namely, monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies.
providus

General Information


Serial Number99310861
Word MarkPROVIDUS
Filing DateWednesday, July 30, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific and technological services, namely, scientific research, pharmaceutical drug development, and biochemical analysis in the field of drug discovery; medical research and conducting clinical trials for pharmaceutical products; data computer modeling services in the field of pharmaceutical development and medical technology; Scientific services and research namely conducting scientific pharmaceutical product feasibility studies and product designing medical devices and instruments for clinical trials; Scientific services and product design, namely conducting scientific pharmaceutical product feasibility studies and designing medical devices and instruments for clinical trials; Platform as a service (PAAS) comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; product research services, design and development of instruments for control and diagnostics; Scientific research; Electronic data storage; Technical writing, namely medical writing services for the development of medical protocols, clinical study reports, researcher pamphlets, safety reports, informed consent forms, meeting summaries, posters, manuscripts, study diagrams, manuals, and literature reviews; Design, implementation and management of clinical and observational clinical research study protocols; Electronic storage of files and documents; computer diagnostic services; computer systems analysis services; providing online non-downloadable software featuring clinical study and clinical trial management system tools via a website; providing online non-downloadable software featuring access to study management files; programming of software for study management files and electronic storage services for archiving temporary files throughout the clinical study lifecycle; scientific research, namely programming of software for biostatistics, development of protocols for sample size and statistical power calculations, randomization plans, statistical analysis plans; programming of computer software for validation in a statistical analysis system for others; providing online non-downloadable software enabling interpretation and reporting of data for clinical trial reports and publications; product development for others; scientific research, namely intermediate analysis for early decision making in clinical trials; providing online non-downloadable software for providing access to databases and data lists ready for a New Drug Application (NDA), regulatory submission-compliant data files, study data tabulation and data on model regulatory submission standards; medical research and development for new products for others in the field of medical surveillance and safety plans ongoing oversight of patient-level studies and review of safety data, interpretation of study protocol, consultation on potential safety and medical issues and 24/7 medical surveillance coverage; pharmaceutical drug development services; drug discovery services of adverse events from clinical trials; pharmaceutical drug development services, namely, development of safety update reports and other aggregate reports, development of management safety plans and medical surveillance plans; product quality testing of clinical trial's documentation, for example, standard operating procedures (sops) and work instructions, internal system reviews, site audits, provider evaluations; Medical research in the field of pharmacology namely simulation, dose selection and optimization, biomarker and endpoint selection, study design optimization, population pharmacokinetic and pharmacodynamic modeling, exposure response modeling; Medical research; Information related to scientific and medical research in the area of clinical trials, namely the design of clinical trials and outcome measures for studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; scientific research in the nature of conducting clinical trials for third parties studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Custom computer programming in the field of image training and integration into computer systems of suitability data with interactive response technology (IRT); product design and development of computer databases for the collection, storage, management, analysis and validation of data for use in the medical and pharmaceutical fields; electronic data storage services for archiving presentations; Providing information on clinical studies via an interactive website.
Indication of Colors claimedThe color(s) blue, teal, white, sage green, dark green, medium green is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "PROVIDUS" in stylized blue font followed by a diagonal blue line, a diagonal teal line, a diagonal white line, a diagonal sage green line, a diagonal dark green line, and a diagonal medium green line.
Goods and ServicesHealthcare services, namely, monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code042
First Use Anywhere DateFriday, June 20, 2025
First Use In Commerce DateFriday, June 20, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code044
First Use Anywhere DateFriday, June 20, 2025
First Use In Commerce DateFriday, June 20, 2025

Trademark Owner History


Party NameITALFARMACO S.P.A.
Party Type10 - Original Applicant
Legal Entity Type35 - NOT AVAILABLE
AddressMilan (MI) 20126
IT

Trademark Events


Event DateEvent Description
Wednesday, July 30, 2025NEW APPLICATION ENTERED
Wednesday, July 30, 2025APPLICATION FILING RECEIPT MAILED
Monday, December 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 8, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 15, 2025ASSIGNED TO EXAMINER
Friday, December 19, 2025NON-FINAL ACTION WRITTEN
Friday, December 19, 2025NON-FINAL ACTION E-MAILED
Friday, December 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 3, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 3, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 3, 2026TEAS/EMAIL CORRESPONDENCE ENTERED